Pharmafile Logo

TVF Communications

- PMLiVE

CNX Therapeutics appoints Erin Federman as non-executive director

Federman previously held roles at Novo Nordisk and Mylan

- PMLiVE

A Pharma Brand Manager’s Guide to Exhibiting

Securing your exhibition space is a significant milestone. The contract is signed, the floorplan is confirmed and the event is in the calendar. So what happens next? Exhibiting successfully involves...

Apex Events and Exhibitions

- PMLiVE

J&J’s nipocalimab gets FDA Fast Track designation for lupus

The autoimmune disease affects approximately three to five million people globally

- PMLiVE

emc3 Collective launches human-centred healthcare events brand

emc3 Life aims to bring a fresh, human-centred perspective to healthcare events

- PMLiVE

Novo Nordisk to invest 432m euros to expand manufacturing facility in Ireland

Construction is expected to be completed in phases from the end of 2027 into 2028

- PMLiVE

Medivir appoints Patrik Norgren as new CFO

Norgen will take on the role as of 23 March

- PMLiVE

Medscape Launches “Where Public Health Meets Practice” Learning Center to Translate Public Health Strategies into Patient Care

  The Medscape Division of Public Health announced the launch of the "Where Public Health Meets Practice" Learning Center, a dedicated educational destination on Medscape.org. The new center serves as...

Medscape Education

- PMLiVE

US FDA launches ultra-rare diseases framework

The draft guidance specifically discusses genome editing and RNA-based therapies

- PMLiVE

N4 Pharma appoints David Solomon as CEO

The company is to be renamed Thalia Therapeutics to reflect its strategic transition

- PMLiVE

Why stigma is a launch risk in rare disease – and what commercial leaders can do about it

Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: stigma.

Havas Life London

- PMLiVE

New report identifies stigma as a structural barrier in rare disease

The study finds that healthcare settings are a leading source of stigma for people living with rare conditions

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links